TREM-1, TREM-2 and their association with disease severity in patients with COVID-19

References

• Huang L, Li X, Gu X, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):1–9. doi: 10.1016/S2213-2600(22)00126-6.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
   PubMed Web of Science ®Google Scholar
• Li J, Lai S, Gao GF, et al. The emergence, genomic diversity and global spread of SARS-CoV-2. Nature. 2021;600(7889):408–418. doi: 10.1038/s41586-021-04188-6.
   PubMed Web of Science ®Google Scholar
• Hu B, Guo H, Zhou P, et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141–154. doi: 10.1038/s41579-020-00459-7.
   PubMed Web of Science ®Google Scholar
• Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–793. doi: 10.1001/jama.2020.12839.
   PubMed Web of Science ®Google Scholar
• Palmieri L, Vanacore N, Donfrancesco C, et al. Clinical characteristics of hospitalized individuals dying with COVID-19 by age group in Italy. J Gerontol A Biol Sci Med Sci. 2020;75(9):1796–1800. doi: 10.1093/gerona/glaa146.
   PubMed Web of Science ®Google Scholar
• Davis HE, McCorkell L, Vogel JM, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133–146. doi: 10.1038/s41579-022-00846-2.
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi: 10.1016/S0140-6736(20)30628-0.
   PubMed Web of Science ®Google Scholar
• Liu F, Li L, Xu M, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;127:104370. doi: 10.1016/j.jcv.2020.104370.
   PubMed Web of Science ®Google Scholar
• Tan C, Huang Y, Shi F, et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol. 2020;92(7):856–862. doi: 10.1002/jmv.25871.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta. 2020;505:190–191. doi: 10.1016/j.cca.2020.03.004.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5.
   PubMed Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848. doi: 10.1007/s00134-020-05991-x.
   PubMed Web of Science ®Google Scholar
• Wilson JG, Simpson LJ, Ferreira AM, et al. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight. 2020;5(17):e140289. doi: 10.1172/jci.insight.140289.
   Web of Science ®Google Scholar
• Qin R, He L, Yang Z, et al. Identification of parameters representative of immune dysfunction in patients with severe and fatal COVID-19 infection: a systematic ­review and meta-analysis. Clin Rev Allergy Immunol. 2023;64(1):33–65. doi: 10.1007/s12016-021-08908-8.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi: 10.1001/jama.2016.0287.
   PubMed Web of Science ®Google Scholar
• Ljungström LR, Jacobsson G, Claesson BEB, et al. Respiratory viral infections are underdiagnosed in patients with suspected sepsis. Eur J Clin Microbiol Infect Dis. 2017;36(10):1767–1776. doi: 10.1007/s10096-017-2990-z.
   PubMed Web of Science ®Google Scholar
• Colonna M. The biology of TREM receptors. Nat Rev Immunol. 2023;23(9):580–594. doi: 10.1038/s41577-023-00837-1.
   PubMedGoogle Scholar
• Klesney-Tait J, Turnbull IR, Colonna M. The TREM receptor family and signal integration. Nat Immunol. 2006;7(12):1266–1273. doi: 10.1038/ni1411.
   PubMed Web of Science ®Google Scholar
• Deczkowska A, Weiner A, Amit I. The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell. 2020;181(6):1207–1217. doi: 10.1016/j.cell.2020.05.003.
   PubMed Web of Science ®Google Scholar
• Arts RJ, Joosten LA, van der Meer JW, et al. TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J Leukoc Biol. 2013;93(2):209–215. doi: 10.1189/jlb.0312145.
   PubMed Web of Science ®Google Scholar
• Matos AO, Dantas P, Silva-Sales M, et al. TREM-1 isoforms in bacterial infections: to immune modulation and beyond. Crit Rev Microbiol. 2021;47(3):290–306. doi: 10.1080/1040841X.2021.1878106.
   PubMed Web of Science ®Google Scholar
• Liu D, Dong Y, Liu Z, et al. Impact of TREM-2 gene silencing on inflammatory response of endotoxin-induced acute lung injury in mice. Mol Cell Biochem. 2014;394(1-2):155–161. doi: 10.1007/s11010-014-2091-6.
   PubMed Web of Science ®Google Scholar
• Hoogendijk AJ, Blok DC, Garcia Laorden MI, et al. Soluble and cell-associated triggering receptor expressed on myeloid cells-1 and -2 in patients with pulmonary tuberculosis. J Infect. 2015;71(6):706–709. doi: 10.1016/j.jinf.2015.09.002.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhang X, Dong W, et al. TREM2 suppresses the proinflammatory response to facilitate PRRSV infection via PI3K/NF-κB signaling. PLoS Pathog. 2020;16(5):e1008543. doi: 10.1371/journal.ppat.1008543.
   PubMed Web of Science ®Google Scholar
• Hiremath J, Renu S, Tabynov K, et al. Pulmonary inflammatory response to influenza virus infection in pigs is regulated by DAP12 and macrophage M1 and M2 phenotypes. Cell Immunol. 2020;352:104078. doi: 10.1016/j.cellimm.2020.104078.
   PubMed Web of Science ®Google Scholar
• Suchankova M, Urban J, Ganovska M, et al. TREM-1 and TREM-2 expression on CD14(+) cells in bronchoalveolar lavage fluid in pulmonary sarcoidosis and hypersensitivity pneumonitis in the context of T cell immune response. Mediators Inflamm. 2020;2020:9501617–9501619. doi: 10.1155/2020/9501617.
   PubMed Web of Science ®Google Scholar
• Wang TY, Feng JY, Shu CC, et al. Plasma concentrations of sTREM-1 as markers for systemic adverse reactions in subjects treated with weekly rifapentine and isoniazid for latent tuberculosis infection. Front Microbiol. 2022;13:821066. doi: 10.3389/fmicb.2022.821066.
   PubMed Web of Science ®Google Scholar
• Sun GY, Guan CX, Zhou Y, et al. Vasoactive intestinal peptide re-balances TREM-1/TREM-2 ratio in acute lung injury. Regul Pept. 2011;167(1):56–64. doi: 10.1016/j.regpep.2010.11.008.
   PubMedGoogle Scholar
• Ren X, Wen W, Fan X, et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021;184(7):1895–1913.e19. doi: 10.1016/j.cell.2021.01.053.
   PubMed Web of Science ®Google Scholar
• Zhang F, Gan R, Zhen Z, et al. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals. Signal Transduct Target Ther. 2020;5(1):156.
   PubMed Web of Science ®Google Scholar
• Zhang JY, Wang XM, Xing X, et al. Single-cell landscape of immunological responses in patients with COVID-19. Nat Immunol. 2020;21(9):1107–1118. doi: 10.1038/s41590-020-0762-x.
   PubMed Web of Science ®Google Scholar
• Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533. doi: 10.1001/jama.2012.5669.
   PubMed Web of Science ®Google Scholar
• Ponti G, Maccaferri M, Ruini C, et al. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57(6):389–399. doi: 10.1080/10408363.2020.1770685.
   PubMed Web of Science ®Google Scholar
• Jiyong J, Tiancha H, Wei C, et al. Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis. Intensive Care Med. 2009;35(4):587–595. doi: 10.1007/s00134-008-1333-z.
   PubMed Web of Science ®Google Scholar
• Wu K, Byers DE, Jin X, et al. TREM-2 promotes macrophage survival and lung disease after respiratory viral infection. J Exp Med. 2015;212(5):681–697. doi: 10.1084/jem.20141732.
   PubMed Web of Science ®Google Scholar
• Donlan AN, Sutherland TE, Marie C, et al. IL-13 is a driver of COVID-19 severity. JCI Insight. 2021;6(15):e150107. doi: 10.1172/jci.insight.150107.
   PubMed Web of Science ®Google Scholar
• Matos AO, Dantas P, Queiroz H, et al. TREM-2: friend or foe in infectious diseases? Crit Rev Microbiol. 2022;20(1):1–19. doi: 10.1080/1040841X.2022.2146481.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wu M, Ming S, et al. TREM-2 promotes Th1 responses by interacting with the CD3ζ-ZAP70 complex following Mycobacterium tuberculosis infection. J Clin Invest. 2021;131(17):e137407.
   Web of Science ®Google Scholar
• Jay TR, von Saucken VE, Landreth GE. TREM2 in neurodegenerative diseases. Mol Neurodegener. 2017;12(1):56.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang M, Yin H, et al. TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection. Sci Adv. 2021;7(50):eabi6802. doi: 10.1126/sciadv.abi6802.
   PubMed Web of Science ®Google Scholar
• Williams P, McWilliams C, Soomro K, et al. The dynamics of procalcitonin in COVID-19 patients admitted to intensive care unit—a multi-centre cohort study in the South West of England, UK. J Infect. 2021;82(6):e24–e26. doi: 10.1016/j.jinf.2021.03.011.
   PubMed Web of Science ®Google Scholar